Alliance for Regenerative Medicine
- District of Columbia
Based in Washington, D.C., the Alliance for Regenerative Medicine (ARM) is the preeminent global advocacy organization for the regenerative and advanced therapies community. ARM fosters research, development, investment and commercialization of transformational treatments and cures for patients worldwide. ARM empowers multiple stakeholders to promote legislative, regulatory and public understanding of, and support for, this expanding field.
ARM has more than 220 members worldwide. Prior to ARM’s formation in 2009, there was no advocacy organization operating in D.C. that specifically represented the interests of the many stakeholders of this sector – the life sciences companies, research and academic institutions, patients and patient advocacy groups, investors and more.
Stakeholder Coordination— A Critical Factor for Success
Delivering cures through regenerative medicine requires coordination amongst a broad range of stakeholder groups from industry, academia, government, healthcare professionals, the investment community and consumer advocates. The Alliance for Regenerative Medicine is the voice for these groups, drawing them together to create an influential and unified community that is paving the way for a healthier future with many new life saving therapies.
About Regenerative Medicine
Regenerative medicine represents a new paradigm in human health with the potential to resolve unmet medical needs by addressing the underlying causes of disease.
The emerging field of regenerative medicine is unique in its aim to augment, repair, replace or regenerate organs and tissue that have been damaged by disease, injury or even the natural aging process. This rapidly evolving, interdisciplinary field is transforming healthcare by translating fundamental science into a variety of regenerative technologies including biologics, chemical compounds, materials and devices. It differs from other fields of medicine in the array of disciplines it brings together and in its ability to create or harness the body's innate healing capacity.
ARM's membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research, and other organizations supporting regenerative medicine.
WHAT WE DO Alliance members work together to:
- Serves as the voice of the global regenerative medicine community.
- Coalesces multiple, diverse stakeholders to ensure the healthcare system supports ready access to regenerative medicine products.
- Introduces and supports policies that pave the way for development of new regenerative medicine therapies, medical devices and diagnostics.
- Including developing and advocating for legislative, regulatory and reimbursement initiatives that support increased research and development of regenerative medicine products.
- Promotes government and private funding of R&D in regenerative medicine.
- Works with regulators including the U.S. Food and Drug Administration (FDA) to encourage more rapid clinical translation of regenerative medicine technologies.
- Works with private insurers and CMS to develop reimbursement models that support development of innovative regenerative medicine products.
- Provides business development and investor outreach services to support the growth of its member companies and research organizations.
- Improves communication, cooperation and public understanding of the field and its potential to transform healthcare.
- Develops public education materials to raise awareness about the value of regenerative medicine products.
- Works with the patient advocacy community to improve understating of regenerative medicine and collaborate on initiatives to advance research and development of the field.
- Creates visibility for advances in the field.